Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

NCT04818541 is registered in ClinicalTrials.gov with Vivasure Medical Limited as lead sponsor.

NCT NCT04818541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04818541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention
Lead sponsor
Vivasure Medical Limited
Phase
Not applicable
Overall status
Completed
Start date
June 29, 2021
Completion date
March 1, 2023
Enrollment
19 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous large hole vascular closure